A National Survey of Hereditary Angioedema and Acquired C1 Inhibitor Deficiency in the United Kingdom
The Journal of Allergy and Clinical Immunology: In Practice · 2023
DOI: 10.1016/j.jaip.2023.04.035 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2023. Verfasst von Patrick F K Yong und 48 weiteren Autor:innen. Beteiligte Einrichtung: Department of Allergy and Clinical Immunology, Frimley Health NHS Foundation Trust, Frimley, United Kingdom. Electronic address: patrick.yong@nhs.net. Hauptthemen laut MEDLINE: Angioedemas, Hereditary. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Detailed demographic data on people with hereditary angioedema (HAE) and acquired C1 inhibitor deficiency in the United Kingdom are relatively limited. Better demographic data would be beneficial in planning service provision, identifying areas of improvement, and improving care. OBJECTIVE: To obtain more accurate data on the demographics of HAE and acquired C1 inhibitor deficiency in the United Kingdom, including treatment modalities and services available to patients. METHODS: A survey was distributed to all centers in the United Kingdom that look after patients with HAE and acquired C1 inhibitor deficiency to collect these data. RESULTS: The survey identified 1152 patients with HAE-1/2 (58% female and 92% type 1), 22 patients with HAE with normal C1 inhibitor, and 91 patients with acquired C1 inhibitor deficiency. Data were provided by 37 centers across the United Kingdom. This gives a minimum prevalence of 1:59,000 for HAE-1/2 and 1:734,000 for acquired C1 inhibitor deficiency in the United Kingdom. A total of 45% of patients with HAE were on long-term prophylaxis (LTP) with the most used medication being danazol (55% of all patients on LTP). Eighty-two percent of patients with HAE had a home supply of acute treatment with C1 inhibitor or icatibant. A total of 45% of patients had a supply of icatibant and 56% had a supply of C1 inhibitor at home. CONCLUSIONS: Data obtained from the survey provide useful information about the demographics and treatment modalities used in HAE and acquired C1 inhibitor deficiency in the United Kingdom. These data are useful for planning service provision and improving services for these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Allergy and Clinical Immunology, Frimley Health NHS Foundation Trust, Frimley, United Kingdom. Electronic address: patrick.yong@nhs.net.
- Regional Immunology Service, Belfast Health and Social Care Trust, Belfast, United Kingdom.
- Department of Immunology, University Hospital of Wales, Cardiff, Wales, United Kingdom.
- Department of Immunology, Manchester University NHS Foundation Trust, Manchester, United Kingdom.
- Department of Immunology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.
- Department of Clinical Immunology, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
Zitieren
APA
Yong, P. F. K., Coulter, T., El-Shanawany, T., Garcez, T., Hackett, S., Jain, R., Kiani-Alikhan, S., Manson, A., Noorani, S., Stroud, C., Symons, C., Sargur, R., Steele, C., Alachkar, H., Anantharachagan, A., Arkwright, P. D., Bernatoniene, J., Bhole, M., Brown, L., …, & Worth, A. (2023). A National Survey of Hereditary Angioedema and Acquired C1 Inhibitor Deficiency in the United Kingdom. The Journal of Allergy and Clinical Immunology: In Practice. https://doi.org/10.1016/j.jaip.2023.04.035
Vancouver
Yong PFK, Coulter T, El-Shanawany T, Garcez T, Hackett S, Jain R, et al. A National Survey of Hereditary Angioedema and Acquired C1 Inhibitor Deficiency in the United Kingdom. The Journal of Allergy and Clinical Immunology: In Practice. 2023. doi:10.1016/j.jaip.2023.04.035
BibTeX
@article{Yong2023,
author = {Yong, Patrick F K and Coulter, Tanya and El-Shanawany, Tariq and Garcez, Tomaz and Hackett, Scott and Jain, Rashmi and Kiani-Alikhan, Sorena and Manson, Ania and Noorani, Sadia and Stroud, Catherine and Symons, Christine and Sargur, Ravishankar and Steele, Cathal and Alachkar, Hana and Anantharachagan, Ariharan and Arkwright, Peter D and Bernatoniene, Jolanta and Bhole, Malini and Brown, Lindsay and Buckland, Matthew and Burns, Siobhan and Chopra, Charu and Darroch, James and Drewe, Elizabeth and Edmonds, Jillian and Ekbote, Anjali and Elkhalifa, Shuayb and Goddard, Sarah and Grosse-Kreul, Dorothea and Gurugama, Padmalal and Hague, Rosie and Herriot, Richard and Herwadkar, Archana and Hughes, Stephen M and Jones, Laura and Lear, Sara and McDermott, Elizabeth and Kham Murng, Sai Hurng and Price, Arthur and Redenbaugh, Vyanka and Richter, Alex and Riordan, Andrew and Shackley, Fiona and Stichbury, Julia and Springett, Debbie and Tarzi, Michael D and Thomas, Moira and Vijayadurai, Pavaladurai and Worth, Austen},
title = {A National Survey of Hereditary Angioedema and Acquired C1 Inhibitor Deficiency in the United Kingdom},
journal = {The Journal of Allergy and Clinical Immunology: In Practice},
year = {2023},
doi = {10.1016/j.jaip.2023.04.035}
}
EUVIMED